Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Patrick M. Honoré, Emily Perriens, Sydney Blackman
Abstract
et al. investigated the role of S100A8/A9, a pro-inflammatory alarmin, in sepsis-induced myocardial dysfunction (SIMD).They concluded that elevated S100A8/A9 is associated with the development of left ventricular (LV) dysfunction in severe sepsis patients [1].Patients 18 years of age and older admitted to the intensive care unit (ICU) with septic shock (per Sepsis III) were included in this study [1].Thirty-five out of sixtytwo (56%) patients had LV dysfunction.Plasma S100A8/ A9 was significantly higher in LV dysfunction patients (20.1 g/mL vs. 7.4 g/mL, P = 0.009).Nearly half of critically ill patients, especially with septic shock, develop acute kidney injury (AKI), and 20-25% require renal replacement therapy (RRT) within the first ICU week [2].Considering S100A8 (10.8 kDa) and S100A9 (13.2 kDa) molecular weights, as well as the molecular weight of the S100A8/A9 heterodimer (24 kDa) [3], continuous RRT (CRRT)-which has a cut-off value of 35-40 kDa-might eliminate these molecules, impacting bio marker levels, and potentially leading to artificially decreased S100A8/ A9 levels [4,5].The absence of CRRT/RRT in the criteria and its impact on each group is a potential major comfounding factor that could heavily influence results [4,5].In a clinical setting, this could lead to inaccurate prognosis and unadapted support.It is necessary that a sensitivity analysis should be done after the exclusion of CRRT/RRT patients to clarify the performance of these biomarkers when they are not artificially removed by an extracorporeal purification technique [5].